Evidence map›Paper›PMID 41706414›Full record

ArticleRadiological physics and technology2026

Enhancing proton therapy for superficial lesions using patient-specific bolus and multi-leaf collimator.

Yushi Wakisaka, Yuki Tominaga, Xing Li, Caroline Bamberger, Jackeline Castro, Kuan Ling Chen, Malgorzata D'Souza, Robabeh Rahimi

Abstract read
PubMed Publisher
In one paragraph

Article in Radiological physics and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yushi WakisakaDepartment of Radiotherapy, Medical Co. Hakuhokai, Osaka Proton Therapy Clinic, Osaka, Japan.ORCID http://orcid.org/0000-0001-6428-1137
Yuki TominagaMedical Physics Laboratory, Division of Health Science, Graduate School of Medicine, The University of Osaka, Osaka, Japan.ORCID http://orcid.org/0000-0002-7851-6213
Xing LiLoyola University Chicago Stritch School of Medicine, Maywood, IL, USA.
Caroline BambergerInova Schar Cancer Institute, Fairfax, VA, USA.ORCID http://orcid.org/0009-0003-6364-0574
Jackeline CastroInova Schar Cancer Institute, Fairfax, VA, USA.
Kuan Ling ChenInova Schar Cancer Institute, Fairfax, VA, USA.
Malgorzata D'SouzaSoftware Company in Halifax, Adaptiiv Medical Technologies Inc., Nova Scotia, Canada.
Robabeh RahimiDepartment of Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, USA. rrahimi@som.umaryland.edu.ORCID http://orcid.org/0000-0002-7651-5479

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In scanning proton therapy for superficial tumors, offset range shifters (ORS) may degrade the lateral penumbra as the air gap increases. This study evaluated the dosimetric benefit of replacing ORS with 3D-printed patient-specific boluses (PSBs) and assessed the effectiveness of combining PSBs with multi-leaf collimators (MLCs). Head and breast phantoms were CT-scanned, and 4-cm-thick PSBs made of thermoplastic polyurethane (TPU) and silicone were fabricated. PSBs were modeled in the treatment planning system using measured water-equivalent thickness (WET). Virtual planning target volumes were defined in superficial layers. Treatment plans were generated with ORS or PSB, with and without MLC, at air gaps of 5–20 cm. Dose conformity was assessed using the conformity index at the 50% isodose level (CI50%) and penumbra width (distance from 80% to 20% dose). To validate dose calculations with PSBs, measured lateral dose distributions were compared with calculations using gamma analysis (3%/2 mm). With ORS, CI50% was 2.45 ± 0.08/2.57 ± 0.05 and penumbra was 15.6 ± 1.2 mm/15.1 ± 1.38 mm for head/breast cases, showing inferior conformity. PSBs achieved higher conformity regardless of air gap. When combined with MLCs, PSBs provided the best results (CI50% = 1.93 ± 0.03/2.04 ± 0.02; penumbra = 3.7 ± 0.4 mm/4.1 ± 0.1 mm). Gamma pass rates exceeded 95% in all cases, confirming agreement between measurement and calculation. PSBs improved dose conformity compared with ORSs in superficial proton therapy, and their combination with MLCs further enhanced treatment quality.

Indexed as

Proton TherapyBreast NeoplasmsHumansPhantoms, ImagingPrinting, Three-DimensionalRadiotherapy DosageRadiotherapy Planning, Computer-AssistedTomography, X-Ray Computed3D-printed bolusMulti-leaf collimatorPatient-specific bolusProton therapyTreatment planning

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.